- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
7
7 companies
Consun Pharmaceutical Group
Market Cap: HK$10.8b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$12.51
7D
-6.9%
1Y
11.9%
CanSino Biologics
Market Cap: HK$9.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$21.80
7D
-2.9%
1Y
-39.1%
InnoCare Pharma
Market Cap: HK$22.7b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.76
7D
0.5%
1Y
-20.4%
China Medical System Holdings
Market Cap: HK$24.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$10.17
7D
-3.8%
1Y
-17.2%
JBM (Healthcare)
Market Cap: HK$1.9b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.96
7D
-16.6%
1Y
-37.8%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.4b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.32
7D
-15.6%
1Y
6.4%
Pak Fah Yeow International
Market Cap: HK$738.6m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.40
7D
-1.2%
1Y
-4.0%